Article Text

PDF

Efficacy and safety of suanzaoren decoction for chronic insomnia disorder in adults: study protocol for randomised, double-blind, double-dummy, placebo-controlled trial
  1. Qi-Hui Zhou,
  2. Hui-Lin Wang,
  3. Xiao-Li Zhou,
  4. Meng-Bei Xu,
  5. Hong-feng Zhang,
  6. Li-bo Huang,
  7. Guo-qing Zheng,
  8. Yan Lin
  1. Department of Neurology, The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, China
  1. Correspondence to Professor Guo-qing Zheng; gq_zheng{at}sohu.com Dr. Yan Lin; linyanm{at}vip.sina.com

Abstract

Background Insomnia disorder is defined as a combination of dissatisfaction with sleep quantity or quality and a significant negative impact on daytime functioning. Chronic insomnia disorder refers to clinical symptoms of persistent insomnia at least three nights a week for at least 3 months. Prevalence estimates of insomnia disorder range from 12% to 20% in the adult population, with approximately 50% having a chronic course. The potential side effects of hypnotic medications hinder their clinical application. Thus, traditional Chinese medicine is considered as an alternative option for treating insomnia.

Objective To evaluate the efficacy and safety of suanzaoren decoction (SZRD), a classic Chinese herbal prescription, for adult chronic insomnia disorder.

Methods/analysis This is a randomised, double-blind, double-dummy, placebo-controlled clinical trial. A total of 150 patients with chronic insomnia disorder are randomised, allocated in a ratio of 1:1:1 to three groups: intervention group, control group and placebo group. The intervention group receives SZRD granule plus zolpidem tartrate (ZT) placebo; the control group receives ZT tablet plus SZRD granule placebo; and the placebo group receives ZT placebo and SZRD granule placebo. The patients receive medicine or placebo for 5 weeks and are followed up at 20 weeks. The primary outcome measures are polysomnography and Pittsburgh Sleep Quality Index. Secondary outcome measures are the Insomnia Severity Index, sleep diary and safety assessment. Outcomes will be assessed at baseline and after treatment.

Trial registration number ChiCTR-IOR-16009198. pre-results.

  • Suanzaoren decoction
  • chronic insomnia disorder
  • study protocol

This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/

Statistics from Altmetric.com

Footnotes

  • Q-HZ and H-LW contributed equally and are co-first authors.

  • Contributors YL and G-qZ are the senior authors and the principal investigators of this study. Q-HZ, H-LW, X-LZ and M-BX wrote the first draft of the manuscript and contributed to the design of the study. G-qZ and YL refined the protocol. H-fZ and L-bH, the medical statisticians for the study, contributed to the statistical design, acquisition and analysis of data. All authors revised the protocol critically for important intellectual content and approved the final manuscript.

  • Funding This project is supported by a grant from the young and middle-aged university discipline leaders of Zhejiang Province, China (2013277); Zhejiang provincial program for the cultivation of high-level health talents (2015). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Ethics committee, the Second Affiliated Hospital of Wenzhou Medical University, China.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data sharing statement The study results will be available after publication in a peer-reviewed medical journal.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.